Released Mar 31, 2021, after the close
10-K filed Mar 31, 2021, 90 days after period end · 0001437749-21-007838
Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.21M$2.21M derived−3.9% vs Q4 2019+77.5% vs Q3 2020
Net Income-$1.08M-$1.08M derivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,388,639−9.8%
Operating Incomederived-$1,194,894N/M
Operating Cash Flowderived-$638,768N/M
Free Cash Flowderived-$638,768N/M
Margins · derived
Gross margin62.8%−4.1 pt vs Q4 2019
Operating margin-54.0%−5.1 pt vs Q4 2019
Net margin-48.8%+75.6 pt vs Q4 2019
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.21M | $2.30M | $3.77M | $2.22M |
| Net Income | -$1.08M | -$2.86M | $178.16K | -$1.79M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Scientific Inc. · CIK 855683 · Engraved from SEC EDGAR